RemeGen Co., Ltd.(688331) Stock Price Today

CN Stock MarketDetailed Quotes

688331 RemeGen Co., Ltd.

Watchlist

50.73
-5.25-9.38%

Market Closed Apr 29 15:00 CST

27.61BMarket Cap-20.11P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Hong Kong stock movement | REMEGEN (09995) drops 7% after earnings, with first-quarter revenue increasing nearly 60% year-on-year, and losses narrowing to 0.254 billion yuan.
REMEGEN (09995) fell by 7% after its earnings report. Notably, the stock had previously increased by more than double in the last month. As of the time of writing, it is down 7%, priced at 38.5 Hong Kong dollars, with a trading volume of 0.277 billion Hong Kong dollars.
Zhitong Finance21:58 ET
Rongchang Biotech: Rongchang Biopharmaceutical (Yantai) Co., Ltd. Report for the first quarter of 2025
SZSI12:00 ET · Announcements
Rongchang Biopharmaceutical (Yantai) Co., Ltd. 2025 First Quarter Report
SZSI12:00 ET · Announcements
Express News | RemeGen - Qtrly Operating Revenue RMB526 Mln
ReutersApr 28 07:21 ET
REMEGEN: 2025 FIRST QUARTERLY REPORT
HKEXApr 28 07:20 ET · Announcements
Zhitong Hong Kong stock short position statistics | April 28
Zhitong Hong Kong Stock Short Position Holding | April 28
Zhitong FinanceApr 28 06:30 ET

Comments

Moomoo AI

Mar 23, 2024 09:21

RemeGen's high P/S ratio, driven by current investor sentiment and future expectations, may be concerning given the company's less than stellar revenue forecasts. Unless conditions improve, these prices may not be reasonable.

RemeGen Co., Ltd.'s (HKG:9995) Shares Climb 29% But Its Business Is Yet to Catch Up

Moomoo AI

Feb 7, 2024 09:09

Despite RemeGen's subdued revenue growth projections, it trades at a P/S ratio similar to the industry, suggesting investors may be less bearish than analysts. However, its weaker revenue outlook could risk a share price decline and pose a risk to shareholders.

Some Confidence Is Lacking In RemeGen Co., Ltd. (HKG:9995) As Shares Slide 47%

Jade Ruby

Jan 25, 2024 11:46

$REMEGEN (09995.HK)$ This shitty stock

Spinee

Jan 17, 2024 16:21

HSI Plunge Once Deepens to 620 Pts; Pharmas In Sell-off

$Hang Seng Index (800000.HK)$ plunge deepened unceasingly after midday. It once stumbled 620 pts or 3.9% to bottom at 15,245, hitting an over-14-month low; last at 15,320, down 545 pts or 3.4%, with a total turnover of $88.5 billion.
Pharmaceuticals were sold off. $REMEGEN (09995.HK)$ once collapsed 27.5% to $22.8; last at $24.9, down 21%.
$CLOVER BIO-B (02197.HK)$ nosedived 9.6% to $0.47, hitting record low. $VIVA BIOTECH (01873.HK)$ ...

SEA Hedge

Dec 15, 2021 15:56

In FT's story, The commerce department is expected to place more than two dozen Chinese companies on the entity list on Thursday, including some involved in biotechnology.
The news triggers the sell-off in Hong Kong.
$WUXI BIO (02269.HK)$ $WUXI APPTEC (02359.HK)$ $CLOVER BIO-B (02197.HK)$ $REMEGEN (09995.HK)$

Stocks & Markets Analysis

688331 RemeGen Co., Ltd.

Trade Overview

Capital Trend

News

Comments

Market Insights

Market Headlines

Latest News